"Fatty Acid Desaturases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of enzymes that catalyze the stereoselective, regioselective, or chemoselective syn-dehydrogenation reactions. They function by a mechanism that is linked directly to reduction of molecular OXYGEN.
| Descriptor ID |
D044943
|
| MeSH Number(s) |
D08.811.682.690.708.392
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fatty Acid Desaturases".
Below are MeSH descriptors whose meaning is more specific than "Fatty Acid Desaturases".
This graph shows the total number of publications written about "Fatty Acid Desaturases" by people in this website by year, and whether "Fatty Acid Desaturases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatty Acid Desaturases" by people in Profiles.
-
Impact of Amerind ancestry and FADS genetic variation on omega-3 deficiency and cardiometabolic traits in Hispanic populations. Commun Biol. 2021 07 28; 4(1):918.
-
Whole Blood DNA Methylation Signatures of Diet Are Associated With Cardiovascular Disease Risk Factors and All-Cause Mortality. Circ Genom Precis Med. 2020 08; 13(4):e002766.
-
Characterization of an arachidonic acid-deficient (Fads1 knockout) mouse model. J Lipid Res. 2012 Jul; 53(7):1287-95.
-
Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res. 2008 May 15; 68(10):3985-91.
-
The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol. 1993 Aug; 11(1):37-47.